
Communicating emerging, trusted scientific information to healthcare professionals (HCPs). Pfizer sponsored, intended for U.S. HCPs. Our community guidelines can be found here: pfi.sr/JJG

Pfizer sponsored. Posts are intended for US healthcare professionals (HCPs) only and may not be suitable outside the US. pfi.sr/qr5

Communicating emerging, trusted scientific information to healthcare professionals (HCPs). Pfizer sponsored, intended for U.S. HCPs. Our community guidelines can be found here: pfi.sr/JJG

Explore the latest science in transthyretin amyloid cardiomyopathy (ATTR-CM) from Pfizer Medical at #ISA2026. Visit Pfizer Medical website to access scientific presentations and resources on diagnosis, quality of life, outcomes, and disease monitoring. pfi.sr/ex9jKw

Looking for clinical evidence in anticoagulation? Explore the new Pfizer Medical Knowledge Hub, featuring selected RCT and RWE study summaries in NVAF and VTE. Optimized for desktop, tablet & mobile, so the evidence goes wherever you go. pfi.sr/MKHresource

How does baseline AD severity affect short- and long-term response to a JAKi across clinical and patient-reported outcomes? Read the results of a recently published exploratory post-hoc analysis in Dermatology and Therapy. pfi.sr/CDqe2n

New publication! How do long-term SALT score trajectories evolve in adolescents with severe alopecia areata? Explore findings from a post hoc analysis of the ALLEGRO clinical development program. Read the full publication to learn more. pfi.sr/idZagR

New publication! Explore findings from a Delphi consensus statement developed to provide expert recommendations for the management of severe alopecia areata. pfi.sr/1xCnvK

New publication in the Journal of Endocrine Society reports 5 year data of a once-weekly treatment for pediatric growth hormone deficiency. academic.oup.com/jes/article…

Watch the latest videos from Pfizer Hemophilia Medical, covering unmet needs, hemophilia care, insights on treatments from experts, and more. View the playlist here: pfi.sr/ytph

How should vitiligo severity and relapse be defined? Explore findings from an international consensus statement developed to support consistent assessment in clinical care of vitiligo. pfi.sr/xXjW9O

Read the results of an exploratory post-hoc analysis evaluating how well patients with moderate-to-severe AD maintained disease control on- and off-treatment with a JAKi. pfi.sr/8lNTff

Join us today at 2:30 PM for the VESPER Phase 2b poster presentations at #ObesityWeek2026

Read about the post hoc exploratory analysis of pooled data assessing the effectiveness and tolerability of a CGRP receptor antagonist in Hispanic or Latino ethnicity adults for the acute treatment of migraine. #neurotwitter pfi.sr/CTGLYn

Recent data at #ACR26: a JAK inhibitor in early active axial spondyloarthritis, long-term data in juvenile idiopathic arthritis, and the impact of idiopathic inflammatory myopathies. Explore the latest insights on Pfizer Medical. pfi.sr/gnJO1f

New real-world migraine study The Migraine Insights in Diagnosis and Treatment (MIND) study, a retrospective cohort study of newly diagnosed with migraine in the US, describes diagnosis and treatment patterns over the 3 years after diagnosis. Full article pfi.sr/MINDstudy

New Publication! How do a JAK inhibitor and biologic achieve skin clearance in chronic hand eczema? Explore findings from a prespecified exploratory analysis in adults with moderate-to-severe atopic dermatitis and CHE. pfi.sr/g6X1Bh

Join Pfizer at #ObesityWeek2026! Check out our poster presentations and visit our booth #601 to learn more. pfi.sr/jkneuz
